Gufic BioScience

{
  "main_header": {
    "sid": 338998,
    "name": "Gufic BioScience",
    "stock_name": "Gufic BioScience",
    "full_name": "Gufic BioSciences Ltd",
    "name_url": "stocks-analysis/gufic-bioscience",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "357.05",
    "chg": 1.05,
    "chgp": "0.29%",
    "dir": 1,
    "prev_price": "356.00",
    "mcapval": "3,578.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 509079,
    "symbol": "GUFICBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE742B01025",
    "curr_date": "Jun 22, 10:29 AM",
    "curr_time": "10:31 AM",
    "last_traded_at": "Jun 22, 10:29 AM IST",
    "bse_nse_vol": "10.02 k",
    "exc_status": "Active",
    "traded_date": "Jun 22, 2026",
    "traded_date_str": "2026 06 22",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gufic-bioscience-338998-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4054920",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_technicaldot_4054920.png",
        "date": "2026-06-16 08:01:56",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Hold to Sell as of 11 June 2026. Despite a strong year-to-date return outperforming the Sensex, recent price action and technical indicators suggest a sideways trend with mixed signals, warranting a cautious stance among investors."
      },
      {
        "title": "Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4053386",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_technicaldot_4053386.png",
        "date": "2026-06-15 08:01:29",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent upgrade in technical trend, the company’s overall MarketsMOJO grade has been downgraded from Hold to Sell, reflecting a complex interplay of bullish and bearish signals across multiple timeframes and indicators."
      },
      {
        "title": "Gufic BioSciences Gains 10.35%: 4 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-gains-1035-4-key-factors-driving-the-weeks-momentum-4052998",
        "imagepath": "",
        "date": "2026-06-14 12:04:11",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>1 June:</strong> Stock surges 3.67% to ₹347.20 despite Sensex decline</p>\n                    <p><strong>2 June:</strong> Mixed technical signals amid mildly bearish momentum</p>\n                    <p><strong>3 June:</strong> Upgrade to Hold rating following strong quarterly results</p>\n                    <p><strong>4 June:</strong> Technical momentum shifts to mildly bullish with 3.73% gain</p>\n                    <p><strong>5 June:</strong> Week closes at ₹369.55, up 3.65% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.334.90</div></div>\n..."
      },
      {
        "title": "Gufic BioSciences Gains 0.47%: 3 Key Factors Driving the Week’s Mixed Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-gains-047-3-key-factors-driving-the-weeks-mixed-momentum-4051571",
        "imagepath": "",
        "date": "2026-06-13 14:04:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>8 June:</strong> Stock rallies 1.83% despite Sensex decline</p>\n                    <p><strong>9 June:</strong> Continued strong gains, up 3.10%</p>\n                    <p><strong>10 June:</strong> Sharp 6.33% drop amid valuation recalibration</p>\n                    <p><strong>11 June:</strong> Valuation shifts signal price attractiveness change</p>\n                    <p><strong>12 June:</strong> Downgrade to Sell and technical momentum shifts</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.369.55</div></div>\n                    <div class=\"stat-item\">..."
      },
      {
        "title": "Gufic BioSciences Ltd Downgraded to Sell Amid Mixed Technicals and Expensive Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-downgraded-to-sell-amid-mixed-technicals-and-expensive-valuation-4048334",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_mojoScore_4048334.png",
        "date": "2026-06-12 08:03:44",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 11 June 2026. The downgrade follows a comprehensive reassessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive quarterly results, the company faces challenges in sustaining long-term growth and valuation concerns amid mixed technical signals."
      },
      {
        "title": "Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4048243",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_technicaldot_4048243.png",
        "date": "2026-06-12 08:01:17",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators present a complex picture, with bullish signals on weekly charts contrasting bearish cues on monthly timeframes, prompting a reassessment of the stock’s near-term outlook."
      },
      {
        "title": "Gufic BioSciences Ltd Valuation Shifts Signal Price Attractiveness Change Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-valuation-shifts-signal-price-attractiveness-change-amid-sector-dynamics-4045690",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_valuationdot_4045690.png",
        "date": "2026-06-11 08:00:18",
        "description": "Gufic BioSciences Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and impacts the stock’s price attractiveness relative to its historical levels and peer group within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Gufic BioSciences Ltd Upgraded to Hold as Financial and Technical Trends Improve",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gufic-biosciences-ltd-upgraded-to-hold-as-financial-and-technical-trends-improve-4035390",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_mojoScore_4035390.png",
        "date": "2026-06-04 08:07:40",
        "description": "Gufic BioSciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement in its financial performance and technical indicators. The upgrade, effective from 3 June 2026, follows a positive quarterly report for March 2026 and a shift in technical trends, signalling cautious optimism for investors in this small-cap pharmaceutical player."
      },
      {
        "title": "Gufic BioSciences Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gufic-biosciences-ltd-shows-technical-momentum-shift-amid-mixed-indicator-signals-4035161",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GuficBioScience_technicaldot_4035161.png",
        "date": "2026-06-04 08:01:19",
        "description": "Gufic BioSciences Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, supported by a blend of positive and cautious signals across key technical indicators. This development comes alongside a significant 3.73% gain in the stock price, reflecting renewed investor interest in the pharmaceuticals and biotechnology sector."
      }
    ],
    "total": 574,
    "sid": "338998",
    "stock_news_url": "https://www.marketsmojo.com/news/gufic-biosciences-338998"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-Jun-2026",
      "details": "Newspaper Advertisement regarding Special Window for Re-lodgement of Transfer and Dematerialization of physical shares is attached herewith.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "05-Jun-2026",
      "details": "Written Transcript of Earnings Conference Call held on June 01 2026 at 04:30 PM is attached herewith.",
      "source": "BSE"
    },
    {
      "caption": "Corrigendum And Clarification To Intimation Dated May 29 2026 Regarding Subscription To Shares Of Saraswat Co-Operative Bank Limited",
      "datetime": "02-Jun-2026",
      "details": "Corrigendum and Collaboration to Intimation dated May 29 2026 regarding Subscription to Shares of Saraswat Co-operative Bank Limited is attached herewith",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gufic BioSciences Ltd has declared <strong>10%</strong> dividend, ex-date: 22 Sep 25",
          "dt": "2025-09-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-16 08:01:56

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflected in a downgrade of its Mojo Grade from Hold to Sell as of 11 June 2026. Despite a strong year-to-date return outperforming the Sensex, recent price action and technical indicators suggest a sideways trend with mixed signals, warranting a cautious stance among investors.

Read full news article

Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-06-15 08:01:29

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent upgrade in technical trend, the company’s overall MarketsMOJO grade has been downgraded from Hold to Sell, reflecting a complex interplay of bullish and bearish signals across multiple timeframes and indicators.

Read full news article

Gufic BioSciences Gains 10.35%: 4 Key Factors Driving the Week’s Momentum

2026-06-14 12:04:11

Key Events This Week

1 June: Stock surges 3.67% to ₹347.20 despite Sensex decline

2 June: Mixed technical signals amid mildly bearish momentum

3 June: Upgrade to Hold rating following strong quarterly results

4 June: Technical momentum shifts to mildly bullish with 3.73% gain

5 June: Week closes at ₹369.55, up 3.65% on the day

Week Open

Rs.334.90

...

Read full news article

Gufic BioSciences Gains 0.47%: 3 Key Factors Driving the Week’s Mixed Momentum

2026-06-13 14:04:42

Key Events This Week

8 June: Stock rallies 1.83% despite Sensex decline

9 June: Continued strong gains, up 3.10%

10 June: Sharp 6.33% drop amid valuation recalibration

11 June: Valuation shifts signal price attractiveness change

12 June: Downgrade to Sell and technical momentum shifts

Week Open

Rs.369.55

...

Read full news article

Gufic BioSciences Ltd Downgraded to Sell Amid Mixed Technicals and Expensive Valuation

2026-06-12 08:03:44

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 11 June 2026. The downgrade follows a comprehensive reassessment across four critical parameters: Quality, Valuation, Financial Trend, and Technicals. Despite some positive quarterly results, the company faces challenges in sustaining long-term growth and valuation concerns amid mixed technical signals.

Read full news article

Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-12 08:01:17

Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators present a complex picture, with bullish signals on weekly charts contrasting bearish cues on monthly timeframes, prompting a reassessment of the stock’s near-term outlook.

Read full news article

Gufic BioSciences Ltd Valuation Shifts Signal Price Attractiveness Change Amid Sector Dynamics

2026-06-11 08:00:18

Gufic BioSciences Ltd has witnessed a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and impacts the stock’s price attractiveness relative to its historical levels and peer group within the Pharmaceuticals & Biotechnology sector.

Read full news article

Gufic BioSciences Ltd Upgraded to Hold as Financial and Technical Trends Improve

2026-06-04 08:07:40

Gufic BioSciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement in its financial performance and technical indicators. The upgrade, effective from 3 June 2026, follows a positive quarterly report for March 2026 and a shift in technical trends, signalling cautious optimism for investors in this small-cap pharmaceutical player.

Read full news article

Gufic BioSciences Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals

2026-06-04 08:01:19

Gufic BioSciences Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, supported by a blend of positive and cautious signals across key technical indicators. This development comes alongside a significant 3.73% gain in the stock price, reflecting renewed investor interest in the pharmaceuticals and biotechnology sector.

Read full news article

View All News